These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6157952)

  • 21. Vascular dopamine receptors: Demonstration and characterization by in vitro studies.
    Brodde OE
    Life Sci; 1982 Jul; 31(4):289-306. PubMed ID: 6292644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sulpiride and the effect of dopamine on the kidney in human salt retention].
    Agnoli GC; Cacciari M; Garutti C; Lenzi P
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):311-7. PubMed ID: 552845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselectivity of presynaptic autoreceptors modulating dopamine release.
    Arbilla S; Langer SZ
    Eur J Pharmacol; 1981 Dec; 76(4):345-51. PubMed ID: 6173239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sulpiride (stereoisomers, racemic) and dopamine: actions and interactions on renal circulation].
    Agnoli GC; Andreone P; Cacciari M; Garutti C; Ikonomu E; Lenzi P
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):169-74. PubMed ID: 6704243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptors on adrenal chromaffin cells modulate calcium uptake and catecholamine release.
    Bigornia L; Suozzo M; Ryan KA; Napp D; Schneider AS
    J Neurochem; 1988 Oct; 51(4):999-1006. PubMed ID: 2458437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
    Woodman OL; Rechtman MP; Lang WJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine produces forearm vasodilatation following alpha-adrenoceptor blockade by an action on vascular dopamine (DA1) receptors in man.
    Hughes AD; Thom SA; Woodall NM; Redman D; Sever PS
    J Hypertens; 1987 Jun; 5(3):337-40. PubMed ID: 2886541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526.
    Ohlstein EH; Zabko-Potapovich B; Berkowitz BA
    J Pharmacol Exp Ther; 1984 May; 229(2):433-9. PubMed ID: 6143817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of the renal vasodilator activity of dopamine by metoclopramide.
    Hahn RA; Wardell JR
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(2):177-82. PubMed ID: 7453834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The vasoconstrictive effect of dopamine in the isolated, perfused rat kidney after catecholamine depletion.
    Augustin HJ; Baumgarten HG; Huland H; Leichtweiss HP
    Res Exp Med (Berl); 1977 Apr; 169(1):1-5. PubMed ID: 17142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in renal blood flow in the rat during renal nerve stimulation: the effects of alphs-adrenergic blockers and a dopaminergic blocker [proceedings].
    Chapman BJ; Horn NM; Munday KA; Robertson MJ
    J Physiol; 1979 Jun; 291():64P-65P. PubMed ID: 39166
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment.
    Higashi H; Inanaga K; Nishi S; Uchimura N
    J Physiol; 1989 Jan; 408():587-603. PubMed ID: 2550628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of sympathetic nervous system in the vascular actions of dopamine.
    Lokhandwala MF; Jandhyala BS
    J Pharmacol Exp Ther; 1979 Jul; 210(1):120-6. PubMed ID: 36477
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
    Hom GJ; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
    Listinsky JJ; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis.
    Nisoli E; Tonello C; Memo M; Carruba MO
    J Pharmacol Exp Ther; 1992 Nov; 263(2):823-9. PubMed ID: 1359119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries.
    Hughes AD; Sever PS
    Br J Pharmacol; 1989 Jul; 97(3):950-6. PubMed ID: 2474354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
    Kazawa T; Mikuni M; Higuchi T; Arai I; Takahashi K; Yamauchi T
    Life Sci; 1990; 47(6):531-7. PubMed ID: 2402179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.